EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
2.3.1.135 | additional information | retinoic acid must be continuously present to maintain LRAT gene expression in the ON position | Rattus norvegicus | |
2.3.1.135 | additional information | activation and mRNA expression for LRAT is blocked completely in vivo by actinomycin D | Rattus norvegicus | |
2.3.1.135 | retinoic acid | minimal dose for significant increase in LRAT activity and mRNA expression: 0.005 mg | Rattus norvegicus |
EC Number | Cloned (Comment) | Organism |
---|---|---|
2.3.1.135 | expression in HEK-293T cells | Rattus norvegicus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.3.1.135 | Rattus norvegicus | Q9JI61 | - |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.3.1.135 | liver | - |
Rattus norvegicus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.135 | phosphatidylcholine + retinol-(cellular-retinol-binding-protein) | - |
Rattus norvegicus | 2-acylglycerophosphocholine + retinyl ester-(cellular-retinol-binding-protein) | - |
? |